Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Follow Three Bays Capital’s Buying Spree In This Semiconductor Stock?

Page 1 of 2

According to a recent filing with the Securities and Exchange Commission, Matthew Sidman‘s Three Bays Capital has hiked  its stake in Cypress Semiconductor Corporation (NASDAQ:CY) by a massive 10.27 million shares to 18.49 million shares. The holding represents 5.6% of the company’s outstanding stock. We decided to analyze if Three Bays’ move warrants an investment in the company in question based on hedge fund activity and insider trading, or whether Three Bays is swimming in the wrong bay on this one. Let’s see if we can decide.


As it turns out, Sidman is not the only big-time money manager bullish on Cypress Semiconductor Corporation (NASDAQ:CY) right now. Hedge funds were extremely bullish on the stock during the first quarter as hedge fund interest in the company climbed by 2.2 percentage points over the previous quarter. Among the firms that we track, a total of 39 had an investment of $1.07 billion in the company at the end of March, compared to just 23 funds with $263.26 million in shares at the end of the previous quarter.

Matthew Sidman
Matthew Sidman
Three Bays Capital

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 145% and beating the market by more than 84 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise (while avoiding their high fees at the same time) rather than large-cap stocks.

The company was lately involved in a bidding war for Integrated Silicon (NASDAQ:ISSI), which it lost to the Chinese investor group Uphill. Cypress Semiconductor Corporation (NASDAQ:CY)’s $22.60 per share bid was outdone by Uphill’s $23 per share offer. Although Cypress missed both the top and bottom line estimates for its first quarter financial results, the company has provided strong guidance for the second quarter. The range of revenue provided by the company, of between $475 million and $500 million is better than the consensus estimate of $482.3 million at the midpoint, while the EPS range of $0.11 to $0.15 also has a significant upside possibility when compared with the $0.12 estimate.

This has been made possible by the company’s $5 billion merger with Spansion (NYSE:CODE), which has transformed Cypress Semiconductor Corporation (NASDAQ:CY) into an embedded systems company, given its dominant position in touch-sensing controllers and SRAMs; now it has flash memory and microcontrollers under its belt too, owing to the acquisition. The company is trading relatively cheaply when its twelve month trailing price-to-sales ratio of 5.12 is compared with the industry’s rather bloated average of 35.52. Moreover, Cypress Semiconductor Corporation (NASDAQ:CY) also offers a dividend yield of 3.73%.

As far as insider trading is concerned, Raymond H Bingham, who is a director at Cypress Semiconductor Corporation (NASDAQ:CY) sold about 176,530 shares of the company in May. Another insider sale was made by the company’s executive vice president, Daniel J McCranie, who sold about 315,422 shares at the end of April.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!